Amplifon (OTCMKTS:AMFPF) & Alignment Healthcare (NASDAQ:ALHC) Head to Head Contrast

Amplifon (OTCMKTS:AMFPF) and Alignment Healthcare (NASDAQ:ALHC) are both mid-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, profitability, risk, earnings, institutional ownership, analyst recommendations and dividends.

Valuation & Earnings

This table compares Amplifon and Alignment Healthcare”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Amplifon	$2.61 billion	0.97	$157.31 million	$0.78	14.74
Alignment Healthcare	$3.95 billion	0.86	-$720,000.00	$0.09	181.89

Amplifon has higher earnings, but lower revenue than Alignment Healthcare. Amplifon is trading at a lower price-to-earnings ratio than Alignment Healthcare, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Amplifon and Alignment Healthcare’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Amplifon	4.74%	14.28%	3.89%
Alignment Healthcare	0.47%	11.50%	1.79%

Analyst Recommendations

This is a summary of recent ratings and target prices for Amplifon and Alignment Healthcare, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Amplifon	0	2	2	0	2.50
Alignment Healthcare	0	3	6	2	2.91

Alignment Healthcare has a consensus price target of $24.60, indicating a potential upside of 50.27%. Given Alignment Healthcare’s stronger consensus rating and higher possible upside, analysts clearly believe Alignment Healthcare is more favorable than Amplifon.

Insider & Institutional Ownership

86.2% of Alignment Healthcare shares are held by institutional investors. 5.2% of Alignment Healthcare shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Volatility and Risk

Amplifon has a beta of 0.63, indicating that its share price is 37% less volatile than the S&P 500. Comparatively, Alignment Healthcare has a beta of 1.26, indicating that its share price is 26% more volatile than the S&P 500.

Summary

Alignment Healthcare beats Amplifon on 9 of the 15 factors compared between the two stocks.

About Amplifon

Amplifon S.p.A. engages in the distribution of hearing solutions and the fitting of customized products that help people rediscover various emotions of sound in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company offers Ampli-easy, Ampli-connect, Ampli-energy, and Ampli-mini hearing devices. It also operates Ampli-care, a platform to deliver audiological care experience; and Amplifon App to manage the device functions in real-time directly from smartphone. Amplifon S.p.A. was founded in 1950 and is headquartered in Milan, Italy. Amplifon S.p.A.

About Alignment Healthcare

Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.